Publications by authors named "Mark Marriott"

Claim this Profile
C
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 1.
Jessica Shipley, James Beharry, Wei Yeh, Nabil Seery, Yi Chao Foong, Mark Marriott

Med J Aust· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus recommendations on multiple sclerosis management in Australia and New Zealand: part 2.
Jessica Shipley, James Beharry, Wei Yeh, Nabil Seery, Yi Chao Foong, Mark Marriott

Med J Aust· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of Rhythm Diagnostic Systems' MultiSense in Detection of Arterial Oxygen Saturation and Respiratory Rate During Hypoxia in Humans: Effects of Skin Color and Device Localization.
Charles Evrard, Amina El Attaoui, Cristina Pistea, Irina Enache, Mark Marriott

Sensors (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CLADIN- CLADribine and INnate immune response in multiple sclerosis - A phase IV prospective study.
Mastura Monif, Richard P Sequeira, Andrea Muscat, Sian Stuckey, Paul G Sanfilippo, Mark Marriott

Clin Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutropaenia complications from Ocrelizumab and Rituximab treatment.
Venus Pang, Nabil Seery, Robb Wesselingh, Wei Yeh, Michael Zhong, Mark Marriott

Mult Scler Relat Disord· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of telehealth on health care in a multiple sclerosis outpatient clinic during the COVID-19 pandemic.
Vivien Li, Izanne Roos, Mastura Monif, Charles Malpas, Stefanie Roberts, Mark Marriott

Mult Scler Relat Disord· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure of alemtuzumab therapy in three patients with MOG antibody associated disease.
Sinali O Seneviratne, Mark Marriott, Sudarshini Ramanathan, Wei Yeh, Fabienne Brilot-Turville

BMC Neurol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to treatment in NMOSD: the Australasian experience.
Laura Clarke, Wajih Bukhari, Cullen M O'Gorman, Elham Khalilidehkordi, Simon Arnett, Mark P Marriott

Mult Scler Relat Disord· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.
Laura Clarke, Simon Arnett, Wajih Bukhari, Elham Khalilidehkordi, Sofia Jimenez Sanchez, Mark P Marriott

Front Neurol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study.
Nabil Seery, Sifat Sharmin, Vivien Li, Ai-Lan Nguyen, Claire Meaton, Mark P Marriott

CNS Drugs· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia.
Nabil Seery, Vivien Li, Ai-Lan Nguyen, Izanne Roos, Katherine A Buzzard, Mark P Marriott

Mult Scler Relat Disord· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation.
Elham Khalilidehkordi, Laura Clarke, Simon Arnett, Wajih Bukhari, Sofia Jimenez Sanchez, Mark P Marriott

Front Neurol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical profile of NMOSD in Australia and New Zealand.
Wajih Bukhari, Laura Clarke, Cullen O'Gorman, Elham Khalilidehkordi, Simon Arnett, Mark P Marriott

J Neurol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder.
Amy Kunchok, Charles Malpas, Petra Nytrova, Eva Kubala Havrdova, Raed Alroughani, Mark Marriott

Mult Scler Relat Disord· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and prevalence of NMOSD in Australia and New Zealand.
Wajih Bukhari, Kerri M Prain, Patrick Waters, Mark Woodhall, Cullen M O'Gorman, Mark P Marriott

J Neurol Neurosurg Psychiatry· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult food borne botulism in Australia: The only 2 cases from the last 15years.
Prashanth Ramachandran, Eddie Chan, Michael Poon, Hans T H Tu, Jennifer M Davis, Mark Marriott

J Clin Neurosci· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervical CT scan-guided epidural blood patches for spontaneous intracranial hypotension.
Julian Maingard, Lauren Giles, Mark Marriott, Pramit M Phal

J Clin Neurosci· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote Sensing of Vital Signs: A Wearable, Wireless "Band-Aid" Sensor With Personalized Analytics for Improved Ebola Patient Care and Worker Safety.
Steven R Steinhubl, Mark P Marriott, Stephan W Wegerich

Glob Health Sci Pract· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new era in the treatment of multiple sclerosis.
Simon A Broadley, Michael H Barnett, Mike Boggild, Bruce J Brew, Helmut Butzkueven, Mark Marriott

Med J Aust· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galanin is an autocrine myelin and oligodendrocyte trophic signal induced by leukemia inhibitory factor.
Melissa M Gresle, Helmut Butzkueven, Victoria M Perreau, Anna Jonas, Junhua Xiao, Mark P Marriott

Glia· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 2 new and emerging therapies and their efficacy. MS Neurology Group of the Australian and New Zealand Association of Neurologists.
Simon A Broadley, Michael H Barnett, Mike Boggild, Bruce J Brew, Helmut Butzkueven, Mark Marriott

J Clin Neurosci· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 1 historical and established therapies. MS Neurology Group of the Australian and New Zealand Association of Neurologists.
Simon A Broadley, Michael H Barnett, Mike Boggild, Bruce J Brew, Helmut Butzkueven, Mark Marriott

J Clin Neurosci· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: an Australian and New Zealand perspective: part 3 treatment practicalities and recommendations. MS Neurology Group of the Australian and New Zealand Association of Neurologists.
Simon A Broadley, Michael H Barnett, Mike Boggild, Bruce J Brew, Helmut Butzkueven, Mark Marriott

J Clin Neurosci· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optic nerve diffusion tensor imaging after acute optic neuritis predicts axonal and visual outcomes.
Anneke van der Walt, Scott C Kolbe, Yejun E Wang, Alexander Klistorner, Neil Shuey, Mark Marriott

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.
Anneke Van Der Walt, Simon Sung, Timothy Spelman, Mark Marriott, Scott Kolbe

Neurology· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis